March 11, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

March is #ColorectalCancerAwarenessMonth.  Follow us on Twitter @NRGOnc as we do our part to help promote awareness and screening of colorectal cancer. 



NRG-GI006: Activation Date: March 6, 2019 (posted to  CTSU).




GOG-0213: Amendment 17; version date: November 16, 2018 (posted on  NRG Oncology and CTSU)



NRG-HN004: Amendment 3, version date January 15, 2019 (posted to  CTSU).  Study reopened to Phase II Portion with Amendment 3 – see Study Memorandum dated March 11, 2019.



NRG-LU004: Amendment 1, version date January 23, 2019 (posted to NRG Oncology).  Study reopened with Amendment 1 – see Study Memorandum dated March 6, 2019.





  • OPEN Eligibility Checklists 1 & 2 have been revised and are posted to the CTSU website. Use the revised version date January 30, 2019 immediately.
  • Blank Rave Forms (Lead-In Phase) have been revised and are posted to the CTSU website. Use the revised version date January 22, 2019 immediately.
  • Blank Rave Forms (Phase II/III) have been revised and are posted to the CTSU website. Use the revised version date January 18, 2019 immediately.
  • Specimen Transmittal form (For Peripheral Blood) has been revised and is posted to the CTSU website. Use the revised version date December 13, 2018 immediately.
  • Specimen Transmittal form (For Serum Samples) has been revised and is posted to the CTSU website. Use the revised version date December 26, 2018 immediately.




NRG-BR003: E-mail Blast (posted to CTSU)


NRG-RTOG 1119: Study Memorandum to Encourage Accrual Completion dated March 11, 2019 (posted to CTSU)



NRG-GI002: Memo: Clarification of Timing Requirement for Imaging on Table 2 (posted to CTSU)



NRG-GY004: Data Freeze – March 2019

NRG-GY004 is maturing for the final analysis. Please ensure all data is up to date (including follow-up information), and all queries are answered. We expect to start the final analysis in March 2019.  We will provide the results of this important study to you as soon as possible. If you have any questions please contact Sandy Dascomb at:


NRG-GY007: Currently accruing to the Phase II portion

Read more


Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus

Read more


Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment

Read more



NRG-HN004: A revised patient brochure is now available on the  CTSU website.



The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, March 13.





Safety updates have been issued for the following studies:









Dr. Julian receives 2018 ACMS Richard E. Deitrick Humanity in Medicine Award

 Dr. Thomas B. Julian, chair of NRG Oncology's Communications Committee, received the 2018 Allegheny County Medical Society Richard E. Deitrick Humanity in Medicine Award at the Allegheny County Medical Society Foundation Gala held on March 2, 2019, in Pittsburgh. The award honors a physician who has improved the lives of patients by caring for them with integrity, honesty, and respect for human dignity and who serves as a role model for other physicians. Read more.

NRG Oncology Wants Photos of Our Nurses in Action!

May 6, 2019 is National Nurses Day! Our NRG Oncology Communications Department is collecting pictures of nurses in action at our member institutions so that we can celebrate the work you do on Nurses Day via our social media, email broadcast, and the next newsletter! If you have a photo you would like to share with us, please send it to

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.



Beitler JJ, Switchenko JM, Dignam JJ, McDonald MW, Saba NF, Shin DM, Magliocca KR, Cassidy RJ, El-Deiry MW, Patel MR, Steuer CE, Xiao C, Hudgins PA, Aiken AH, Curran WJ Jr, Le QT. Smoking, age, nodal disease, T stage, p16 status, and riskof distant metastases in patients with squamous cell cancer of the oropharynx. Cancer. 2019 Mar 1;125(5):704-711. doi: 10.1002/cncr.31820. Epub 2018 Dec 11. PubMed PMID: 30548235.  Read more


Brooks RA, Tritchler DS, Darcy KM, Lankes HA, Salani R, Sperduto P, Guntupalli S, DiSilvestro P, Kesterson J, Olawaiye AB, Moxley K, Waggoner S, Santin A, Rader JS, Kizer NT, Thaker PH, Powell MA, Mutch DG, Birrer MJ, Goodfellow PJ. GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2019 Feb 28. pii: S0090-8258(19)30138-6. doi: 10.1016/j.ygyno.2019.02.028. [Epub ahead of print] PubMed PMID: 30827726. Read more


Dawson LA, Winter KA, Katz AW, Schell MC, Brierley J, Chen Y, Kopek N, Crane CH, Willett CG. NRG Oncology/RTOG 0438: A Phase I Trial of Highly Conformal Radiation Therapy for Liver Metastases. Pract Radiat Oncol. 2019 Feb 27. pii: S1879-8500(19)30067-0. doi:  10.1016/j.prro.2019.02.013. [Epub ahead of print] PubMed PMID: 30825666.  Read more


Kavanaugh JA, Holler S, DeWees TA, Robinson CG, Bradley JD, Iyengar P, Higgins KA, Mutic S, Olsen LA. Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials. Pract Radiat Oncol. 2019 Mar;9(2):e218-e227. doi: 10.1016/j.prro.2018.11.007. Epub 2018 Dec 15. PubMed PMID: 30562615  Read more


Thor M, Deasy JO, Paulus R, Lee WR, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM. Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415. Radiotherapy and Oncology. 2019 Mar 5. pii: S0167814019300854. doi: 10.1016/j.radonc.2019.02.014. [Epub ahead of print]  Read more



Please note the following upcoming meeting and abstract submission deadline dates


Upcoming Meetings

American Association for Cancer Research (AACR); Mar 29 - Apr 3, 2019; Atlanta, GA

Society of Gynecologic Oncology (SGO); Mar 16-19, 2019; Honolulu, HI

Society of Surgical Oncology (SSO); Mar 27-30, 2019 ; San Diego, CA

St. Gallen Breast Cancer Conference (SG-BCC); Mar 20-23, 2019; Vienna, Austria


Upcoming Abstract Submission Deadlines

American Society of Clinical Oncology (ASCO); May 31 - Jun 4, 2019; Chicago, IL; LBA Mar14, 2019 noon ET

ESMO Breast Cancer Annual Congress; May 2-4, 2019; Berlin, Germany; LBA deadline Apr 1, 2019 noon CEST (Central European Summer Time)

International Society for Quality of Life Research (ISOQOL); Oct 20-23, 2019; San Diego, CA; due to publications committee Mar 26 2019; meeting submission deadline Apr 8, 2019

Radiological Society of North America (RSNA); Dec 1-6, 2019; Chicago, IL; due to publications committee Mar 27 2019; meeting submission deadline Apr 10, 2019

Western Association of Gynecologic Oncologists (WAGO); Jun 12-15, 2019; Huntington Beach, CA; due to publications committee Mar 11 2019; meeting submission deadline Mar 25, 2019

NRG Oncology is proud to be an active participant of #CancerMoonShot.
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from to
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address | Forward Email | Report Abuse